Head and neck tumor organoid biobank for modelling individual responses to radiation therapy according to the TP53/HPV status
Abstract Background Head and neck cancers (HNC) represent an extremely heterogeneous group of diseases with a poorly predictable therapy outcome. Patient-derived tumor organoids (PDTO) offer enormous potential for individualized therapy testing and a better mechanistic understanding of the main HNC...
| 出版年: | Journal of Experimental & Clinical Cancer Research |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
BMC
2025-03-01
|
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s13046-025-03345-3 |
